Quantcast
Last updated on April 17, 2014 at 16:09 EDT

Latest Michael D. Lockshin Stories

2013-10-28 08:30:22

ALBUQUERQUE, N.M., Oct. 28, 2013 /PRNewswire/ -- Exagen Diagnostics, a leading medical diagnostic company focused in rheumatology, today announced the addition of Arthur Weinstein, M.D., MACR, FRCP, as its newest board member and adviser to Exagen's scientific team. (Logo: http://photos.prnewswire.com/prnh/20131028/LA05125LOGO) Dr. Weinstein is professor of medicine at Georgetown University Medical Center and Associate Chairman, Department of Medicine, and Director, Section of...

2012-10-18 23:20:35

WASHINGTON, Oct. 19, 2012 /PRNewswire-USNewswire/ -- Whoopi Goldberg, physician and renowned researcher Dr. Michael Lockshin, and humanitarians Judith and Wayne Barlin were honored for their work to improve the lives of people with lupus, at the Lupus Foundation of America's annual Butterfly Gala in New York City on October 18. (Photo: http://photos.prnewswire.com/prnh/20121019/DC96318) (Logo: http://photos.prnewswire.com/prnh/20120711/DC38337LOGO) Other special guests at the Gala...

2012-03-05 07:00:00

HAYWARD, Calif., March 5, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases including cardiovascular and autoimmune disorders, today announced the continuation of the Phase 2b PEARL-SC clinical study following an interim analysis of all safety and efficacy data. As part of the ongoing safety monitoring of the PEARL-SC clinical study, the Company's Data Safety Monitoring Board (DSMB) met for the fourth...

2012-03-01 12:09:00

NEW YORK, March 1, 2012 /PRNewswire/ -- Junior investigators embarking on research careers in the New York City metropolitan area may get their first chance at independence in answer to today's request for applications from the S.L.E. Lupus Foundation. Based on unparalleled success in attracting and fostering New York's talent in lupus research, the Foundation is also offering the same opportunity to the up-and-coming scientists of Los Angeles. For over 35 years, the New York-headquartered...

2011-12-01 07:00:00

HAYWARD, Calif., Dec. 1, 2011 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced positive interim biomarker data from the PEARL-SC phase 2b clinical study in patients with systemic lupus erythematosus. After analysis by an independent statistician, data from the on-going PEARL-SC study indicate that weekly and monthly subcutaneous doses of blisibimod resulted in...

2011-11-09 07:11:04

(Ivanhoe Newswire) — Promising research may offer hope for women with lupus who once believed that pregnancy was too risky. According to this study, most women with stable lupus can have successful pregnancies. "There was a misconception, based on outdated experience, that women with lupus should not try to have children," Jane Salmon, M.D., the study's senior author and Collette Kean Research Chair at Hospital for Special Surgery in New York City, was quoted as saying. "Now that our...

2011-11-07 10:35:02

Results from multicenter NIH PROMISSE study find pregnancy safe for 80 percent of women with lupus Promising research led by investigators at Hospital for Special Surgery may offer hope for women with lupus who once thought that pregnancy was too risky. Results from the multicenter National Institutes of Health (NIH) funded PROMISSE initiative, being presented Monday, Nov. 7 and then during a press conference on Tuesday, Nov. 8, during the American College of Rheumatology's 2011 Annual...

2011-10-27 10:32:31

Atorvastatin is safe and may benefit pediatric patients with more severe lupus Atorvastatin therapy was found to be ineffective in reducing atherosclerosis progression in children and adolescents with systemic lupus erythematosus (SLE). Results of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Trial, now available in Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR), report that the statin...

2011-10-27 06:25:44

(Ivanhoe Newswire) -- Women with lupus are 50 times more likely to have a heart attack; and all lupus patients are eight times more likely to develop premature coronary heart disease than the general population. Statins, a class of drug used to lower cholesterol, have been shown to reduce arthrosclerosis progression in adults, but have not been investigated in a pediatric lupus population. Atherosclerosis is a build-up of plaque in the arterial wall which can lead to heart attack and...

2011-03-23 03:35:24

Results may lead to test to identify women at risk of this pregnancy-related complication Scientists have discovered genetic defects that appear to predispose women to a common pregnancy-related medical problem called preeclampsia that can threaten the life of both baby and mother. Lead investigator Jane Salmon, M.D., a rheumatologist and senior scientist at Hospital for Special Surgery in New York City, and colleagues uncovered genetic mutations in women with the autoimmune diseases...